SOME BELIEVE THAT LIQUID BIOPSY TECHNOLOGY has the potential to develop into a Holy Grail of cancer diagnostics. Yet progress in this field has been slow. Now a recent lab acquisition may accelerate the development of clinically-useful liquid biopsies. There is keen interest in how to achieve the noninvasive diagnosis of cancer. Investors have ploughed …
NeoGenomics Acquires Inivata to Access Liquid Biopsy Technology Read More »
